Riyasat Ali

Employment

• The University of Texas Southwestern Medical Center Research Scientist
  2023 - Present
• University of Houston Research Assistant Professor
  2022 - 2023
• University of Houston Research Associate 2
  2018 - 2022
• Albert Einstein College of Medicine Associate
  2018 - 2018
• Albert Einstein College of Medicine
  2016 - 2018
• Yeshiva University Albert Einstein College of Medicine Postdoctoral Fellow
  2013 - 2016
• All India Institute of Medical Sciences Senior Research Fellow
  2009 - 2012
• All India Institute of Medical Sciences Junior Research Fellow
  2006 - 2009

Education

• All India Institute of Medical Sciences Ph.D.
  2008 - 2013
• Jamia Millia Islamia PG Diploma in Bioinformatics
  2003 - 2005
• Jamia Millia Islamia M.Sc.
  2002 - 2004

Projects & Funding

Projects & funding information is unavailable.

Publications (23)

• Angiotensin II type 2 receptor activation preserves megalin in the kidney and prevents proteinuria in high salt diet fed rats.
  Scientific reports 2023 DOI: 10.1038/s41598-023-31454-6
  +Save
• Macrophage angiotensin AT2 receptor activation is protective against early phases of LPS-induced acute kidney injury.
  American journal of physiology. Renal physiology 2023 DOI: 10.1152/ajprenal.00177.2022
  +Save
• Angiotensin type 2 receptor activation limits kidney injury during the early phase and induces Treg cells during the late phase of renal ischemia
  American Journal of Physiology-Renal Physiology 2021 DOI: 10.1152/ajprenal.00507.2020
  +Save
• Emerging Role of Angiotensin AT2 Receptor in Anti-Inflammation: An Update
  Current Pharmaceutical Design 2020 DOI: 10.2174/1381612826666200115092015
  +Save
• Development and Characterization of a Preclinical Model for the Evaluation of CD205-Mediated Antigen Delivery Therapeutics in Type 1 Diabetes
  ImmunoHorizons 2019 DOI: 10.4049/immunohorizons.1900014
  +Save
• HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression
  The Journal of Immunology 2018 DOI: 10.4049/jimmunol.1701652
  +Save
• HLA-B*39:06 Efficiently Mediates Type 1 Diabetes in a Mouse Model Incorporating Reduced Thymic Insulin Expression1
  2018 DOI: 10.1101/264531
  +Save
• CD4+TCRγδ+FoxP3+ cells: An unidentified population of immunosuppressive cells towards disease progression leprosy patients
  Experimental Dermatology 2017 DOI: 10.1111/exd.13302
  +Save
• Genetically modified human CD4+T cells can be evaluatedin vivowithout lethal graft-versus-host disease
  Immunology 2016 DOI: 10.1111/imm.12613
  +Save
• Anti–CD3 Antibody Treatment: a Promising Immunotherapeutic for Type 1 Diabetes
  Journal of Nature and Natural Sciences 2016 DOI: 10.26859/jnnsci.v1i01.9595
  +Save